RAMALINGAM AJIT
Known title: SVP, Chief Accounting OfficerCIK: 0001807891
Associated companies
Transaction History
| BIO | ▲ Buy | Option Exercise | 241 | $0 | 9/2/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 84 | $33K | 9/2/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 173 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 60 | $24K | 9/1/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 169 | $0 | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 59 | $23K | 9/1/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 17 | $6K | 6/6/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 181 | $67K | 6/6/2023 | View on chart |
| BIO | ▲ Buy | Option Exercise | 277 | $0 | 4/29/2023 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 96 | $43K | 4/29/2023 | View on chart |
| BIO | ▼ Sell | Open Market | 267 | $113K | 11/10/2022 | View on chart |
| BIO | ▼ Sell | Open Market | 112 | $47K | 11/10/2022 | View on chart |
| BIO | ▼ Sell | Open Market | 0 | $161 | 11/10/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 241 | $0 | 9/2/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 84 | $40K | 9/2/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 169 | $0 | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 59 | $29K | 9/1/2022 | View on chart |
| BIO | ▼ Sell | Open Market | 518 | $278K | 8/5/2022 | View on chart |
| BIO | ▲ Buy | Option Exercise | 277 | $0 | 4/29/2022 | View on chart |
| BIO | ▼ Sell | Tax Withholding | 96 | $49K | 4/29/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth
The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.
Bio‑Rad Leads in Recombinant Protein & Magnetic Bead Growth. The latest market report shows the recombinant protein manufacturing sector is expected to triple in revenue by 2030, with Bio‑Rad listed among the key players. A separate analysis projects the magnetic bead market to grow from $3.3 billion in 2025 to $7.4 billion by 2032, again naming Bio‑Rad as a leader. These developments highlight the company’s expanding role in both protein production and diagnostic reagent markets.